Samsrita Labs Ltd

Unaudited results publication

• Unaudited standalone and consolidated results for quarter ended 30 June 2026.
• Board approval granted at meeting held on 13 August 2026.
• Newspaper publication on 14 August 2026; QR code links to full results.

Use of proceeds status

• No deviation in use of preferential issue funds for quarter ended 30 June 2026.
• Audit Committee reviewed the statement on 13 August 2026.

Fundraising details and allocations

• Funds raised: 339.10 lakh on 18-07-2025; quarter end 30-06-2026 report.
• Original allocations: Working capital 52.10; New projects 132.46; Promoter loan 88.31; General corporate 66.23.
• Utilized by objective: 52.10; 28.62; 88.31; 56.58 respectively.
• Statement filed for quarter ended 30.06.2026; no deviation reported.

Board approvals

• Board approved standalone and consolidated unaudited results for quarter ended 30 June 2026.
• Limited Review Reports issued by statutory auditors for both standalone and consolidated results.
• Independent Auditor's Review Report states no audit opinion.
• Group's share of PAT from associates: Rs 12.60 Lakhs.
• Associates Krisani Bio Sciences Pvt Ltd and QROPS Advisory Services Pvt Ltd; aggregate net loss Rs 18.87 Lakhs.

AGM Details

• 30th AGM for FY2025-26 held on 10 August 2026 at 11:00 AM IST via VC/OAVM.
• Scrutinizer's Report for AGM submitted under Section 108 of the Companies Act.

AGM Details

• Date and time: 10 August 2026 at 11:00 a.m.
• Mode: Video Conference/OAVM.
• Meeting concluded: 11:36 a.m.
• Record date for voting: 03 August 2026.

Key Resolutions

• Adopt standalone and consolidated financial statements for FY 2025-26.
• Re-appoint Annapantula Vydehi as Director (retiring by rotation).
• Appoint Ravi Kanth Naga Pattabhi Chopperla as Non-executive Director.
• Appoint Satyanarayana Murthy Varanasi as Independent Director.
• Alter MOA object clause.
• Scheme for reduction of share capital.
• Approve related party transaction with Qrops Advisory Services Private Limited.

Voting Results

• Resolution 1: Passed with 54.28% turnout; 99.9996% in favour.
• Resolution 2: Passed with 54.28% turnout; 99.9996% in favour.
• Resolution 3: Passed with 54.28% turnout; 99.9992% in favour.
• Resolution 4: Passed with 54.28% turnout; 99.9992% in favour.
• Resolution 5: Passed with 54.28% turnout; 99.9992% in favour.
• Resolution 6: Passed with 54.28% turnout; 99.9992% in favour.
• Resolution 7: Passed with 36.43% turnout; 99.9992% in favour.

Dividend

• Dividend: Not proposed or declared at this AGM.

Directors & Auditors

• Directors changes: Vydehi reappointed; Chopperla appointed Non-exec; Satyanarayana Murthy Varanasi appointed Independent.
• Auditors: No changes announced; statutory auditors attended; no remuneration details disclosed.

Material Related Party Transactions

• Approval of related party transaction with Qrops Advisory Services Private Limited (associate company).

Other Material Approvals

• Alteration of object clause and capital reduction scheme approved.

AGM details

• AGM date/time/mode: 10 August 2026, 11:00 IST, via VC/OAVM.

Resolutions

• Ordinary: Adopt standalone and consolidated financial statements.
• Ordinary: Reappoint Annapantula Vydehi as director by rotation.
• Special: Appoint Ravi Kanth Naga Pattabhi Chopperla as Non-Executive Director.
• Special: Appoint Satyanarayana Murthy Varanasi as Independent Director.
• Special: Alter Object Clause to insert pet animal healthcare main object.
• Special: Scheme for Reduction of Share Capital, subject to NCLT.
• Ordinary: Approve material related party transaction with QROPS Advisory Services.

Dividend

• Dividend: no dividend proposed or declared.

Director changes

• Annapantula Vydehi to be reappointed.
• Ravi Kanth Naga Pattabhi Chopperla appointed Non-Executive Director.
• Satyanarayana Murthy Varanasi appointed Independent Director.
• Appointments effective from 04 July 2026.

Auditor appointments

• Statutory auditors remain MGR & Co; tenure unchanged.

Material related party transactions

• RPT with QROPS Advisory Services Private Limited (associate) up to ₹15 crores.

Other material approvals

• Alter MOA to add pet healthcare object.
• Capital reduction scheme approved; subject to NCLT confirmation.